{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T04:38:33Z","timestamp":1720845513780},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12185-020-03045-y","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T06:03:08Z","timestamp":1609653788000},"page":"576-585","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30\u00a0years among atomic bomb survivors in Hiroshima"],"prefix":"10.1007","volume":"113","author":[{"given":"Kingo","family":"Fujimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ohisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"3045_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BGM, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspective risk factor for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121\u20137.","journal-title":"Leukemia"},{"key":"3045_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2010.08207.x","volume":"150","author":"JR Berenson","year":"2010","unstructured":"Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, et al. Monoclonal gammopathy of undetermined significance: a consensus statement. Brit J Haematol. 2010;150:28\u201338.","journal-title":"Brit J Haematol"},{"key":"3045_CR3","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412\u20137.","journal-title":"Blood."},{"key":"3045_CR4","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood. 2009;113:5418\u201322.","journal-title":"Blood"},{"key":"3045_CR5","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand J-P, et al. Monoclonal gammmopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120:4292\u20135.","journal-title":"Blood"},{"key":"3045_CR6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3324\/haematol.2009.013961","volume":"94","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Kumar S. The significance of monoclonal gammopathy of undetermined significance. Haematologica. 2009;94:1641\u20134.","journal-title":"Haematologica"},{"key":"3045_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined sinificance: A systematic review. Mayo Clin Proc. 2010;85:933\u201342.","journal-title":"Mayo Clin Proc"},{"key":"3045_CR8","unstructured":"Kato M, Simizu Y. Cancer mortality rates in A-bomb survivors. In: Sigematsu I, Ito C, Kamada N, Akiyama M, Sasaki H, (eds) Effects of A-bomb Radiation on Human Body. Harwood academic publishers. Switzerland. Ltd, Copyright 1995 by Bunkodo Co., Ltd. P. 26\u201339."},{"key":"3045_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<217::AID-AJH15>3.0.CO;2-C","volume":"52","author":"P Pasqualetti","year":"1996","unstructured":"Pasqualetti P, Collacciani A, Casale R. Risk of monoclonal gammopathy of undetermined significance: A case-referent study. Amer J Hematol. 1996;52:217\u201320.","journal-title":"Amer J Hematol"},{"key":"3045_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1182\/blood-2008-12-192575","volume":"114","author":"CM Vachon","year":"2009","unstructured":"Vachon CM, Kyle RA, Thermeau TM, Foreman BJ, Larson DR, Colby CL, et al. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood. 2009;114:785\u201390.","journal-title":"Blood"},{"key":"3045_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","volume":"114","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH, et al. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood. 2009;114:791\u20135.","journal-title":"Blood"},{"key":"3045_CR12","first-page":"204","volume":"304","author":"J Cuzick","year":"1981","unstructured":"Cuzick J. Radition-induced myelomatosis. N Engl. J Med. 1981;304:204\u201310.","journal-title":"J Med"},{"key":"3045_CR13","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","volume":"82","author":"M Iwanaga","year":"2007","unstructured":"Iwanaga M, Tagawa M, Tsukasaki K, Kamihira S, Tomonaga M. Prevalence of monoclonal gammopathy of undetermined significance: Study of 52802 persons in Nagasaki city Japan. Mayo Clin Proc. 2007;82:1474\u20139.","journal-title":"Mayo Clin Proc"},{"key":"3045_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0753-3322(02)00194-4","volume":"56","author":"GJ Morgan","year":"2002","unstructured":"Morgan GJ, Davies FE, Linet M. Myeloma aetiology and epidemiology. Biomed Pharmacother. 2002;56:223\u201334.","journal-title":"Biomed Pharmacother"},{"key":"3045_CR15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2008-05-159665","volume":"113","author":"M Iwanaga","year":"2009","unstructured":"Iwanaga M, Tagawa M, Tsukasaki K, Matsuo T, Yokota K, Miyazki Y, et al. Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki A-bomb survivors. Blood. 2009;113:1639\u201350.","journal-title":"Blood"},{"key":"3045_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1365-2141.2003.04287.x","volume":"121","author":"K Neriishi","year":"2003","unstructured":"Neriishi K, Nakashima E, Suzuki G. Monoclonal gammopathy of undetermined significnance in A-bomb survivors: Incidence and transformation to multiple myeloma. Brit J Haematol. 2003;121:405\u201310.","journal-title":"Brit J Haematol"},{"key":"3045_CR17","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","volume":"111","author":"LM Brown","year":"2008","unstructured":"Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood. 2008;111:3388\u201394.","journal-title":"Blood"},{"key":"3045_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jamaoncol.2018.0509","volume":"4","author":"O Landgren","year":"2018","unstructured":"Landgren O, Zeig-Owens R, Giricz O, Goldfarb D, Murata K, Ramanathan L, et al. Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center Disaster. JAMA Oncol. 2018;4:821\u20137.","journal-title":"JAMA Oncol"},{"key":"3045_CR19","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362\u20139.","journal-title":"N Engl J Med"},{"key":"3045_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hon.2548","volume":"37","author":"L Ma","year":"2019","unstructured":"Ma L, Xu S, Qu J, Hou J, Wang Y, Wen L, et al. Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study. Hematol Oncol. 2019;37:75\u20139.","journal-title":"Hematol Oncol"},{"key":"3045_CR21","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/j.clml.2018.06.005","volume":"18","author":"R Gupta","year":"2018","unstructured":"Gupta R, Dahiya M, Kumar L, Shekhar V, Sharma A, Ramakrishnan L, et al. Prevalence of monoclonal gammopathy of undetermined significance in India-a hospital based study. Clin Lymphoma Myeloma Leuk. 2018;18:e345\u201350.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3045_CR22","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1182\/blood-2012-11-466011","volume":"121","author":"SP Wu","year":"2013","unstructured":"Wu SP, Minter A, Costello R, Zingone A, Lee C-K, Au W-Y, et al. MGUS prevalence in an ethically Chinese population in Hong Kong. Blood. 2013;121:2363\u20134.","journal-title":"Blood"},{"key":"3045_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","volume":"107","author":"O Landgren","year":"2006","unstructured":"Landgren O, Gridleg G, Turesson I, Caporaso NE, Goldin LR, Baris D, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood. 2006;107:904\u20136.","journal-title":"Blood"},{"key":"3045_CR24","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1038\/bcj.2017.97","volume":"7","author":"O Landgren","year":"2017","unstructured":"Landgren O, Graubard BI, Kumar S, Kyle RA, Katzmann JA, Murata K, et al. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10\u201349 years-old: a population-based study from the National Health and Nutrition Examination Survey. Blood Cancer J. 2017;7:e618.","journal-title":"Blood Cancer J"},{"issue":"2","key":"3045_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jamaoncol.2015.23","volume":"1","author":"EE Sigurdardottir","year":"2015","unstructured":"Sigurdardottir EE, Turesson I, Lund SH, Lindqvist EK, Mailankody S, Korde N, et al. The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival in multiple myeloma. JAMA Oncol. 2015;1(2):168\u201374.","journal-title":"JAMA Oncol"},{"key":"3045_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, et al. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378:241\u20139.","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"3045_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12185-018-2555-7","volume":"109","author":"C Kuwabara","year":"2019","unstructured":"Kuwabara C, Sakuma Y, Kume A, Tamura Y, Shimizu R, Iwai R, et al. Characteristics and prognosis of patients with non-immunoglobulin-M monoclonal gammopathy of undetermined significance: a retrospective study. Int J Hematol. 2019;109(2):154\u201361.","journal-title":"Int J Hematol"},{"key":"3045_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/jcp.35.1.63","volume":"35","author":"JP Saleun","year":"1982","unstructured":"Saleun JP, Vicariot M, Deroff P, Morin JF. Monoclonal gammmopathies in the adult population of Finistere. France J Clin Pathol. 1982;35:63\u20138.","journal-title":"France J Clin Pathol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-020-03045-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T18:17:48Z","timestamp":1697480268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-020-03045-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3045"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-03045-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"28 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study design was approved by ethics committees at Yasuda Women\u2019s University (200004) and Hiroshima University (E-118).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}